News
Seoul St. Mary's Hospital, Dankook University centres team up on health tech prototypes
Seoul St. Mary's Hospital, Dankook University centres team up on health tech prototypes
They will reduce prototyping time and costs.
4 days ago
Indonesia anchors Longevity 5.0 amidst regional stem cell gaps
Borderless Healthcare links regenerative medicine with clinics, resorts, and home-based wellness.
RESILIA valves reshape lifetime care planning
Durability data and transcatheter reintervention options are influencing treatment decisions across Asia-Pacific
Tissue valve uptake hinges on data and diagnosis
Durability evidence is shifting younger patient use whilst awareness remains Australia’s main adoption barrier.
RESILIA data widens tissue valve options for younger patients
Awareness and price still slow adoption as durability evidence challenges mechanical valve trade-offs.
GERD device market to hit $1.9b as reflux care goes minimally invasive
India emerged as the fastest-growing market in APAC.
Label identification technologies market to reach $2.87b by 2031
Asia Pacific is expected to be the fastest-growing regional market.
Fertility sensors race to $2.80b by 2033 as at-home testing takes off
Asia Pacific could emerge as the fastest-growing region.
IHH Healthcare, MMA, and Monash University Malaysia partner to strengthen GP-specialist care
Focus areas include diabetes, obesity, cardiovascular health, and emergency care.
Burjeel Holdings’ $500m debut Sukuk draws $1.6b orders
It allowed the Dubai-based firm to tighten pricing.
Taiwan’s NTUH partners with Shu-Zen college on talent, education collaboration
It covers five collaboration areas, including talent exchange.
Hospital demand and AI drive $10b expansion in MRI market in 2036
Hospitals are investing in AI reconstruction to improve scanner utilisation.
Body fluid analysis market to hit $3.65b on neurological and cancer demand
Speciality diagnostics widen across multiple body fluid categories in hospital laboratories.
Global diabetes trials market to double to $10b by 2034
AI-enabled decentralised clinical trials are forecast to grow at a 10.5% CAGR.
China healthcare lags Hong Kong and global markets in 2026
It posted the largest decline in price-to-earnings.
Global dialysis market to hit $141.5b by 2031
Asia Pacific is set to register the highest regional CAGR.
Singapore’s AI tool analyses heart attack damage within one minute
Cardiovascular disease is the leading cause of death in Singapore.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential